Public market insider selling at Aurinia Pharmaceuticals (AUP)

Public market insider selling at Aurinia Pharmaceuticals (T:AUP)

Chin Kyu Huh, a 10% Holder, disposed of 210,333 Common Shares on a control or direction basis for registered holder ILJIN SNT Co., Ltd. at prices ranging from US$15.006 to US$15.097 between September 15th and 17th, 2020. This represents a $4,176,186 divestment of the company's shares and an account share holdings change of -2.5%.

Aurinia Pharmaceuticals is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.

Aurinia Pharmaceuticals Inc. is a late-stage clinical biopharmaceutical company. The Company is focused on developing and commercializing therapies to treat targeted patient populations that are impacted by serious diseases. It is developing voclosporin in multiple indications. Voclosporin is an investigational therapy. It is developing voclosporin for the treatment of lupus nephritis (LN) and other proteinuric diseases. It is also advancing voclosporin ophthalmic solution (VOS), a topical formulation, for the treatment of dry eye syndrome (DES). Voclosporin is a calcineurin inhibitor (CNI). By inhibiting calcineurin, voclosporin blocks IL-2 expression and T-cell mediated immune responses and stabilizes the podocyte in the kidney.